What are the appropriate treatment options for bedwetting (nocturnal enuresis) in children and adults?

Bedwetting Treatment

Start with an enuresis alarm as first-line therapy for children aged 6 years and older with monosymptomatic nocturnal enuresis, as it achieves the highest cure rate (75%) and lowest relapse rate (41%) compared to all other interventions. 1

Initial Assessment and Preparation

Before initiating active treatment, complete these essential steps:

• Exclude constipation and treat if present with polyethylene glycol to achieve daily soft bowel movements 2
• Rule out urinary tract infection with urinalysis 2
• Obtain a frequency-volume chart (bladder diary) to document voiding patterns and nocturnal urine production 2
• Ensure the child is at least 5-6 years old before starting active treatment 2

Behavioral Interventions (Foundation for All Cases)

Implement these measures for every child, regardless of subsequent treatment:

• Regular daytime voiding schedule: morning, twice during school, after school, dinner time, and immediately before bed 2
• Fluid management: Liberal intake during morning/early afternoon, restrict evening intake to ≤200 ml (6 oz), nothing after dinner until morning 2
• Dry/wet night calendar: Has independent therapeutic benefit and tracks progress 2
• Reassure family: Bedwetting is not the child's or parents' fault; it's a common developmental condition 2

First-Line Treatment Options

Option 1: Enuresis Alarm (Preferred for Long-Term Cure)

Best for: Children with reduced bladder capacity or when family seeks curative therapy rather than symptom management.

• Achieves 75% success rate with only 41% relapse 1
• Requires motivated child and family commitment
• Effects take time but are more durable than medication

Option 2: Desmopressin (Preferred for Nocturnal Polyuria)

Best for: Children with documented nocturnal polyuria (nocturnal urine production >130% of expected bladder capacity) or when alarm therapy is impractical 2

Dosing specifics:

• Oral tablets: 0.2-0.4 mg taken 1 hour before bedtime 2
• Oral melt formulation: 120-240 μg taken 30-60 minutes before bedtime 2
• Dose is not weight-based; same for all ages 2
• Effect is immediate if going to work 2

Critical safety warning:

• Avoid nasal spray formulation due to higher risk of water intoxication 2
• Strict fluid restriction: ≤200 ml evening intake, nothing until morning to prevent hyponatremia and seizures 2
• Contraindicated in polydipsia 2

Expected outcomes: 30% full response, 40% partial response, but low curative potential 2

Second-Line Treatment (Treatment-Resistant Cases)

Anticholinergics (Add to Desmopressin)

Only after standard treatment fails and following these mandatory steps 2:

1. Confirm regular voiding habits established
2. Exclude/treat constipation
3. Perform uroflowmetry with post-void residual measurement to exclude dysfunctional voiding 2

Medication options (approximately 40% effective in resistant cases):

• Tolterodine: 2 mg at bedtime (may double) 2
• Oxybutynin: 5 mg at bedtime (may double) 2
• Propiverine: 0.4 mg/kg at bedtime (may double) 2

Often requires combination with desmopressin at standard dose 2

Monitor for:

• Constipation (most common side effect; signals decreasing efficacy) 2
• Post-void residual urine causing UTIs (greatest danger) 2
• Mood changes (less common with tolterodine/propiverine vs. oxybutynin) 2

Expect response within 2 months maximum 2

Third-Line Treatment (Tertiary Care Only)

Imipramine

Reserved for: Tertiary care facilities OR when alarm failed and family cannot afford desmopressin 2

Dosing:

• 25 mg at bedtime for children ≤9 years
• 50 mg at bedtime for children >9 years
• Evaluate after 1 month 2

Critical safety concerns:

• Potentially fatal cardiotoxicity with overdose 2
• Must exclude long QT syndrome with prolonged ECG if any history of palpitations, syncope, sudden cardiac death, or unstable arrhythmia in family 2
• Keep securely locked away from siblings 2
• Mandatory drug holidays: 2 weeks every 3 months to prevent tolerance 2

Approximately 50% response rate 2

Common Pitfalls to Avoid

1. Starting desmopressin without fluid restriction: Risks life-threatening hyponatremia and seizures
2. Using anticholinergics as first-line: They are NOT evidence-based first-line therapy 2
3. Prescribing anticholinergics without checking post-void residual: Risks urinary retention and UTIs
4. Continuing imipramine without drug holidays: Leads to tolerance
5. Treating before age 5-6: Spontaneous resolution rate is high; wait unless family strongly desires earlier intervention
6. Ignoring constipation: Must be addressed before any treatment will work effectively

Treatment Algorithm Summary

1. Age 5-6+ → Behavioral interventions + treat constipation
2. Motivated family → Enuresis alarm (best long-term cure)
3. Nocturnal polyuria or alarm impractical → Desmopressin with strict fluid restriction
4. Failed standard treatment → Check post-void residual → Add anticholinergic to desmopressin
5. Multiple treatment failures → Refer to tertiary care for imipramine consideration